esp | eng
SALVAT News


CRISTALMINA sponsors the central debate of the 5th SEFAC

11/17/12

CRISTALMINA sponsors the central debate of the 5th National Congress of Community Pharmacists (SEFAC): “new mixed retribution model for the dispensation service”

Cristalmina, the pharmacy antiseptic, accompanied community pharmacists and their proposals for new, sustainable pharmacy models.

The proposal aimed to increase the economic viability of pharmacies, irrespective of the price of medicines, and to encourage better professional performance.

The professional fee for dispensations would pay for the professional act of dispensing, in an amount to be revised every year according to the CPI, irrespective of the price of the medicinal product in question.

The SEFAC’s proposal also contemplates an additional viability charge, under special circumstances, in favour of pharmacies with a small number of dispensations per year (less than 25,000).

Some of the main objectives of the new proposal for the remuneration of dispensation services are to increase the amount paid for the dispensation service provided by pharmacies, encouraging pharmacists to act professionally by reducing the morbidity/mortality associated with medicinal products, and to guarantee their economic viability irrespective of the price of medicines. This proposal was presented today by the Spanish Community Pharmacy Society (SEFAC) at the 5th National Congress of Community Pharmacists, which is being held in Barcelona and attended by more than 600 professionals.

Dispensation is the most highly demanded service in community pharmacy so, in SEFAC’s opinion, it should be remunerated without putting the economic viability of pharmacies at risk and as a form of encouraging professional development, none of which is covered by the current model.

SEFAC’s proposal is based on establishing a mixed retribution model, based on a fixed professional fee plus a variable logistic charge. This represents an important change in approach, as pharmacies currently earn an economic margin linked to the price of medicines. Considering the continuous price cuts being applied for some years now, this is putting the survival of many pharmacies at serious risk (especially those that have less than 25,000 dispensations per year).

Under special circumstances, the SEFAC proposal also contemplates an additional viability charge for pharmacies with a small number of dispensations per year (NRD), in order to guarantee accessibility, quality and continuity of the dispensation service for NHS users. The amount in question and the number of dispensations would be periodically reviewed. 

According to SEFAC, the proposed model is a model that looks towards the future, a step forward for community pharmacists regarding their healthcare role and one that provides an incentive for a more professional pharmaceutical dispensation service. It is more patient-focused, ensuring the viability of the network of community pharmacies and opening the door to other interventions and pharmaceutical activities. The ultimate objective is to optimise the healthcare service provided to patients by improving the rational use of medicines and reducing the morbidity/mortality associated with them.

SEFAC also hopes and trusts that this proposal will reach community pharmacists, their representatives and the various healthcare agencies, so that it can be analysed and they can reflect on its contents, in order to promote – as far as they are able – a change in the current system of remuneration for the dispensation of medicines and medical devices provided for the National Health Service by Spanish community pharmacists.



Laboratorios SALVAT S.A.
C\ Gall, 30-36 08950 - Esplugues de Llobregat - Barcelona España Tel. +34 933 946 400 Fax. +34 934 732 292 salvat@svt.com
1200 Brickell Avenue, Suite 1950, Miami, FL 33131 (US) Tel. +1 786-528-5273 salvatusa@svt.com